Instituto Universitario de Investigación en Neuroquímica
Centro/Instituto
![Foto de Instituto Universitario de Investigación en Neuroquímica](/img/uploaded/210288F0EBF11B5B400384EE1F7A6332.jpg)
![Foto de Instituto de Investigación Sanitaria del Hospital Clínico San Carlos](/img/noimage_org.png)
Instituto de Investigación Sanitaria del Hospital Clínico San Carlos
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (25)
2022
-
Editorial: Molecular Mechanisms of Autophagy in Cancer
Frontiers in Cell and Developmental Biology
-
IQM-PC332, a Novel DREAM Ligand with Antinociceptive Effect on Peripheral Nerve Injury-Induced Pain
International Journal of Molecular Sciences, Vol. 23, Núm. 4
-
Safety and Efficacy of Crizotinib in Combination with Temozolomide and Radiotherapy in Patients with Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial
Cancers, Vol. 14, Núm. 10
-
TRIB3 Modulates PPARγ-Mediated Growth Inhibition by Interfering with the MLL Complex in Breast Cancer Cells
International journal of molecular sciences, Vol. 23, Núm. 18
2021
-
Cancer Treatment: Preclinical & Clinical
Journal of the National Cancer Institute - Monographs, Vol. 2021, Núm. 58, pp. 107-113
-
Combining low-density cell culture, single-cell tracking, and patch-clamp to monitor the behavior of postnatal murine cerebellar neural stem cells
STAR Protocols, Vol. 2, Núm. 4
-
The pseudokinase TRIB3 negatively regulates the HER2 receptor pathway and is a biomarker of good prognosis in luminal breast cancer
Cancers, Vol. 13, Núm. 21
2020
-
Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer
The Journal of experimental medicine, Vol. 217, Núm. 6
-
Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells
Theranostics, Vol. 10, Núm. 11, pp. 5120-5136
-
Stromal SNAI2 is required for ERBB2 breast cancer progression
Cancer Research, Vol. 80, Núm. 23, pp. 5216-5230
2019
-
Inhibiting SUMO1-mediated SUMOylation induces autophagy-mediated cancer cell death and reduces tumour cell invasion via RAC1
Journal of Cell Science, Vol. 132, Núm. 20
-
Phosphorylation of FOXO proteins as a key mechanism to regulate their activity
Methods in Molecular Biology (Humana Press Inc.), pp. 51-59
2018
-
Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma
Biochemical Pharmacology, Vol. 157, pp. 275-284
-
Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide
Biochemical Pharmacology, Vol. 157, pp. 266-274
2017
-
The cannabinoid receptor CB1 contributes to the development of ectopic lesions in a mouse model of endometriosis
Human Reproduction, Vol. 32, Núm. 1, pp. 175-184
2016
-
Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization
Autophagy, Vol. 12, Núm. 11, pp. 2213-2229
-
Human Atg8-cardiolipin interactions in mitophagy: Specific properties of LC3B, GABARAPL2 and GABARAP
Autophagy, Vol. 12, Núm. 12, pp. 2386-2403
-
The complex relationship of tribbles pseudokinase 1, PML/RARA and C/EBPα in leukemia: Two possible couples but not a trio
Haematologica
2015
-
AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation
Nature Cell Biology, Vol. 17, Núm. 1, pp. 20-30
-
Autophagy in malignant transformation and cancer progression
EMBO Journal, Vol. 34, Núm. 7, pp. 856-880